 | | 2Z0 | | Name: | N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)
butyl]glycinamide | | Formula: | C26 H37 Cl N7 O7 S | | SMILES: | ClCC(=O)C(NC(=O)CNC(=O)C(NS(=O)(=O)c2ccc1c(cccc1N(C)C)c2)CCC(=O)O)CCCNC(=[NH2+])N | | InChi: | InChI=1S/C26H36ClN7O7S/c1-34(2)21-7-3-5-16-13-17(8-9-18(16)21)42(40,41)33-20(10-11-24(37)38)25(39)31-15-23(36)32-19(22(35)14-27)6-4-12-30-26(28)29/h3,5,7-9,13,19-20,33H,4,6,10-12,14-15H2,1-2H3,(H,31,39)(H,32,36)(H,37,38)(H4,28,29,30)/p+1/t19-,20-/m0/s1 | | Synonyms: | dansyl-Glu-Gly-Arg-chloromethyl-ketone | | Definition date: | 2008-08-28 | | Last modified: | 2024-09-27 | | Identifier: | N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-oxohexan-3-yl]glycinamide |
|
 | | 83K | | Name: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[(1H-indol-3-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide | | Formula: | C45 H64 N6 O6 | | SMILES: | O=C(CCC(CCc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)N(C)C)N1C(=O)C=C(OC)C1Cc1c[NH]c2ccccc12 | | InChi: | InChI=1S/C45H64N6O6/c1-28(2)23-36(48-44(55)37(24-29(3)4)49-45(56)42(30(5)6)50(7)8)43(54)47-33(20-19-31-15-11-10-12-16-31)21-22-40(52)51-38(39(57-9)26-41(51)53)25-32-27-46-35-18-14-13-17-34(32)35/h10-18,26-30,33,36-38,42,46H,19-25H2,1-9H3,(H,47,54)(H,48,55)(H,49,56)/t33-,36-,37-,38-,42-/m0/s1 | | Definition date: | 2021-09-03 | | Last modified: | 2024-09-27 | | Release date: | 2022-03-02 | | Identifier: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[(1H-indol-3-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide |
|
 | | 83N | | Name: | tert-butyl-N-[(2S)-1-[(2S,4S)-4-methoxy-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | | Formula: | C23 H40 N4 O7 | | SMILES: | CO[CH]1C[CH](N(C1)C(=O)[CH](NC(=O)OC(C)(C)C)C(C)C)C(=O)N[CH](CO)C[CH]2CCNC2=O | | InChi: | InChI=1S/C23H40N4O7/c1-13(2)18(26-22(32)34-23(3,4)5)21(31)27-11-16(33-6)10-17(27)20(30)25-15(12-28)9-14-7-8-24-19(14)29/h13-18,28H,7-12H2,1-6H3,(H,24,29)(H,25,30)(H,26,32)/t14-,15-,16-,17-,18-/m0/s1 | | Synonyms: | tert-butyl-N-[(2S)-1-[(2S,4S)-4-methoxy-2-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | | Definition date: | 2021-09-30 | | Last modified: | 2024-09-27 | | Release date: | 2023-05-03 | | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-1-[(2~{S},4~{S})-4-methoxy-2-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate |
|
 | | 2ZC | | Name: | O-{[4-(2-aminoethyl)phenyl]sulfonyl}-L-serine | | Formula: | C11 H16 N2 O5 S | | SMILES: | O=C(O)C(N)COS(=O)(=O)c1ccc(cc1)CCN | | InChi: | InChI=1S/C11H16N2O5S/c12-6-5-8-1-3-9(4-2-8)19(16,17)18-7-10(13)11(14)15/h1-4,10H,5-7,12-13H2,(H,14,15)/t10-/m0/s1 | | Definition date: | 2014-05-01 | | Last modified: | 2024-09-27 | | Release date: | 2014-05-14 | | Identifier: | O-{[4-(2-aminoethyl)phenyl]sulfonyl}-L-serine |
|
 | | 2ZF | | Name: | N-(tert-butoxycarbonyl)-L-alpha-glutamyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide | | Formula: | C21 H33 F2 N3 O9 | | SMILES: | O=C(OC(C)(C)C)NC(C(=O)NC(C(=O)NC(C(=O)C(=O)O)CC(F)F)CC(C)C)CCC(=O)O | | InChi: | InChI=1S/C21H33F2N3O9/c1-10(2)8-13(18(31)24-12(9-14(22)23)16(29)19(32)33)25-17(30)11(6-7-15(27)28)26-20(34)35-21(3,4)5/h10-14H,6-9H2,1-5H3,(H,24,31)(H,25,30)(H,26,34)(H,27,28)(H,32,33)/t11-,12-,13-/m0/s1 | | Definition date: | 2008-12-12 | | Last modified: | 2024-09-27 | | Identifier: | N-(tert-butoxycarbonyl)-L-alpha-glutamyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide |
|
 | | 83W | | Name: | tert-butyl-N-[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2S)-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate | | Formula: | C25 H44 N4 O7 | | SMILES: | C[CH](OC(C)(C)C)[CH](NC(=O)OC(C)(C)C)C(=O)N1CCC[CH]1C(=O)N[CH](CO)C[CH]2CCNC2=O | | InChi: | InChI=1S/C25H44N4O7/c1-15(35-24(2,3)4)19(28-23(34)36-25(5,6)7)22(33)29-12-8-9-18(29)21(32)27-17(14-30)13-16-10-11-26-20(16)31/h15-19,30H,8-14H2,1-7H3,(H,26,31)(H,27,32)(H,28,34)/t15-,16+,17+,18+,19+/m1/s1 | | Synonyms: | tert-butyl-N-[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2S)-2-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate | | Definition date: | 2021-09-30 | | Last modified: | 2024-09-27 | | Release date: | 2023-05-03 | | Identifier: | ~{tert}-butyl ~{N}-[(2~{S},3~{R})-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2~{S})-2-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate |
|
 | | 300 | | Name: | 2-FORMYL-6-METHOXYPHENYL DIHYDROGEN PHOSPHATE | | Formula: | C8 H9 O6 P | | SMILES: | O=Cc1cccc(OC)c1OP(=O)(O)O | | InChi: | InChI=1S/C8H9O6P/c1-13-7-4-2-3-6(5-9)8(7)14-15(10,11)12/h2-5H,1H3,(H2,10,11,12) | | Synonyms: | RU78300 | | Definition date: | 2003-06-20 | | Last modified: | 2024-09-27 | | Identifier: | 2-formyl-6-methoxyphenyl dihydrogen phosphate |
|
 | | 84C | | Name: | tert-butyl-N-[(2S)-1-[(3S,3aS,6aR)-3-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | | Formula: | C25 H42 N4 O6 | | SMILES: | CC(C)[CH](NC(=O)OC(C)(C)C)C(=O)N1C[CH]2CCC[CH]2[CH]1C(=O)N[CH](CO)C[CH]3CCNC3=O | | InChi: | InChI=1S/C25H42N4O6/c1-14(2)19(28-24(34)35-25(3,4)5)23(33)29-12-16-7-6-8-18(16)20(29)22(32)27-17(13-30)11-15-9-10-26-21(15)31/h14-20,30H,6-13H2,1-5H3,(H,26,31)(H,27,32)(H,28,34)/t15-,16-,17-,18-,19-,20-/m0/s1 | | Synonyms: | tert-butyl N-[(2S)-1-[(3S,3aS,6aR)-3-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | | Definition date: | 2021-09-30 | | Last modified: | 2024-09-27 | | Release date: | 2023-05-03 | | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-1-[(3~{S},3~{a}~{S},6~{a}~{R})-3-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate |
|
 | | 30F | | Name: | (2Z)-2-amino-3-selanylprop-2-enoic acid | | Formula: | C3 H5 N O2 Se | | SMILES: | O=C(O)/C(N)=C/[SeH] | | InChi: | InChI=1S/C3H5NO2Se/c4-2(1-7)3(5)6/h1,7H,4H2,(H,5,6)/b2-1- | | Definition date: | 2014-05-06 | | Last modified: | 2024-09-27 | | Release date: | 2015-03-04 | | Identifier: | (2Z)-2-amino-3-selanylprop-2-enoic acid |
|
 | | 30S | | Name: | 2-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid | | Formula: | C15 H14 N4 O4 S | | SMILES: | O=S(=O)(O)c1ccccc1COc3c2c(nc(nc2N)N)ccc3 | | InChi: | InChI=1S/C15H14N4O4S/c16-14-13-10(18-15(17)19-14)5-3-6-11(13)23-8-9-4-1-2-7-12(9)24(20,21)22/h1-7H,8H2,(H,20,21,22)(H4,16,17,18,19) | | Definition date: | 2014-05-14 | | Last modified: | 2024-09-27 | | Release date: | 2015-05-13 | | Identifier: | 2-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid |
|
 | | 30U | | Name: | 4-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid | | Formula: | C15 H14 N4 O4 S | | SMILES: | O=S(=O)(O)c1ccc(cc1)COc3c2c(nc(nc2N)N)ccc3 | | InChi: | InChI=1S/C15H14N4O4S/c16-14-13-11(18-15(17)19-14)2-1-3-12(13)23-8-9-4-6-10(7-5-9)24(20,21)22/h1-7H,8H2,(H,20,21,22)(H4,16,17,18,19) | | Definition date: | 2014-05-15 | | Last modified: | 2024-09-27 | | Release date: | 2015-05-20 | | Identifier: | 4-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid |
|
 | | 30V | | Name: | S-[(2-carbamoylphenyl)selanyl]-L-cysteine | | Formula: | C10 H12 N2 O3 S Se | | SMILES: | O=C(O)C(N)CS[Se]c1ccccc1C(=O)N | | InChi: | InChI=1S/C10H12N2O3SSe/c11-7(10(14)15)5-16-17-8-4-2-1-3-6(8)9(12)13/h1-4,7H,5,11H2,(H2,12,13)(H,14,15)/t7-/m0/s1 | | Definition date: | 2014-05-15 | | Last modified: | 2024-09-27 | | Release date: | 2014-07-08 | | Identifier: | S-[(2-carbamoylphenyl)selanyl]-L-cysteine |
|
 | | 30W | | Name: | N-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide | | Formula: | C9 H7 N5 O3 | | SMILES: | O=C(NC2=Nc1ncc(nc1C(=O)N2)C=O)C | | InChi: | InChI=1S/C9H7N5O3/c1-4(16)11-9-13-7-6(8(17)14-9)12-5(3-15)2-10-7/h2-3H,1H3,(H2,10,11,13,14,16,17) | | Synonyms: | Acetyl 6-formylpterin | | Definition date: | 2014-05-16 | | Last modified: | 2024-09-27 | | Release date: | 2014-07-02 | | Identifier: | N-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide |
|
 | | 31G | | Name: | 3-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid | | Formula: | C15 H14 N4 O4 S | | SMILES: | O=S(=O)(O)c1cccc(c1)COc3c2c(nc(nc2N)N)ccc3 | | InChi: | InChI=1S/C15H14N4O4S/c16-14-13-11(18-15(17)19-14)5-2-6-12(13)23-8-9-3-1-4-10(7-9)24(20,21)22/h1-7H,8H2,(H,20,21,22)(H4,16,17,18,19) | | Definition date: | 2014-05-16 | | Last modified: | 2024-09-27 | | Release date: | 2015-05-20 | | Identifier: | 3-{[(2,4-diaminoquinazolin-5-yl)oxy]methyl}benzenesulfonic acid |
|
 | | 85L | | Name: | [[(2~{R})-2-azanyl-3-oxidanylidene-propyl]-(chloranylaurio)sulfanuidyl]-chloranyl-gold | | Formula: | C3 H6 Au2 Cl2 N O2 S | | SMILES: | N[CH](C[S-]([Au]Cl)[Au]Cl)C(O)=O | | InChi: | InChI=1S/C3H7NO2S.2Au.2ClH/c4-2(1-7)3(5)6 | | Definition date: | 2021-10-01 | | Last modified: | 2024-09-27 | | Release date: | 2023-04-19 | | Identifier: | [[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]-(chloranylaurio)sulfanuidyl]-chloranyl-gold |
|
 | | 31J | | Name: | 7-hydroxy-6-methoxy-3-[2-(2-methoxyethoxy)ethyl]-4,8-dimethyl-2H-chromen-2-one | | Formula: | C17 H22 O6 | | SMILES: | O=C2Oc1c(c(O)c(OC)cc1C(=C2CCOCCOC)C)C | | InChi: | InChI=1S/C17H22O6/c1-10-12(5-6-22-8-7-20-3)17(19)23-16-11(2)15(18)14(21-4)9-13(10)16/h9,18H,5-8H2,1-4H3 | | Definition date: | 2014-05-19 | | Last modified: | 2024-09-27 | | Release date: | 2014-09-03 | | Identifier: | 7-hydroxy-6-methoxy-3-[2-(2-methoxyethoxy)ethyl]-4,8-dimethyl-2H-chromen-2-one |
|
 | | 31K | | Name: | 2-methoxy-6-methyl-4-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)phenol | | Formula: | C17 H19 N O3 | | SMILES: | Oc3c(cc(c2ccc1c(OCCN1C)c2)cc3OC)C | | InChi: | InChI=1S/C17H19NO3/c1-11-8-13(10-16(20-3)17(11)19)12-4-5-14-15(9-12)21-7-6-18(14)2/h4-5,8-10,19H,6-7H2,1-3H3 | | Definition date: | 2014-05-19 | | Last modified: | 2024-09-27 | | Release date: | 2014-09-03 | | Identifier: | 2-methoxy-6-methyl-4-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)phenol |
|
 | | 85P | | Name: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid | | Formula: | C16 H9 Cl F N O5 S | | SMILES: | c1(ccc3c(c1)c(C(O)=O)cc(c2ccc(cc2)Cl)n3)OS(F)(=O)=O | | InChi: | InChI=1S/C16H9ClFNO5S/c17-10-3-1-9(2-4-10)15-8-13(16(20)21)12-7-11(24-25(18,22)23)5-6-14(12)19-15/h1-8H,(H,20,21) | | Definition date: | 2017-01-05 | | Last modified: | 2024-09-27 | | Release date: | 2018-01-17 | | Identifier: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid |
|
 | | 31L | | Name: | 3-methoxy-5-methyl-4'-(morpholin-4-yl)biphenyl-4-ol | | Formula: | C18 H21 N O3 | | SMILES: | Oc1c(cc(cc1OC)c3ccc(N2CCOCC2)cc3)C | | InChi: | InChI=1S/C18H21NO3/c1-13-11-15(12-17(21-2)18(13)20)14-3-5-16(6-4-14)19-7-9-22-10-8-19/h3-6,11-12,20H,7-10H2,1-2H3 | | Definition date: | 2014-05-19 | | Last modified: | 2024-09-27 | | Release date: | 2014-09-03 | | Identifier: | 3-methoxy-5-methyl-4'-(morpholin-4-yl)biphenyl-4-ol |
|
 | | 85Q | | Name: | (2R,4R)-1-(2-chloranylethanoyl)-N-(3-chlorophenyl)-4-phenyl-pyrrolidine-2-carboxamide | | Formula: | C19 H18 Cl2 N2 O2 | | SMILES: | ClCC(=O)N1C[CH](C[CH]1C(=O)Nc2cccc(Cl)c2)c3ccccc3 | | InChi: | InChI=1S/C19H18Cl2N2O2/c20-11-18(24)23-12-14(13-5-2-1-3-6-13)9-17(23)19(25)22-16-8-4-7-15(21)10-16/h1-8,10,14,17H,9,11-12H2,(H,22,25)/t14-,17+/m0/s1 | | Definition date: | 2021-10-04 | | Last modified: | 2024-09-27 | | Release date: | 2022-10-05 | | Identifier: | (2~{R},4~{R})-1-(2-chloranylethanoyl)-~{N}-(3-chlorophenyl)-4-phenyl-pyrrolidine-2-carboxamide |
|
 | | 31Q | | Name: | (4-carboxyphenyl)(L-cysteinato-kappaS~3~)mercury | | Formula: | C10 H11 Hg N O4 S | | SMILES: | O=C(O)C(N)CS[Hg]c1ccc(C(=O)O)cc1 | | InChi: | InChI=1S/C7H5O2.C3H7NO2S.Hg/c8-7(9)6-4-2-1-3-5-6 | | Definition date: | 2014-05-22 | | Last modified: | 2024-09-27 | | Release date: | 2014-07-08 | | Identifier: | (4-carboxyphenyl)(L-cysteinato-kappaS~3~)mercury |
|
 | | 862 | | Name: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | | Formula: | C23 H25 N9 O2 | | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(c3cn(nn3)c4ccc(cc4)C(C)=O)c5c(N)ncnc25 | | InChi: | InChI=1S/C23H25N9O2/c1-3-19(34)30-10-4-5-17(11-30)32-23-20(22(24)25-13-26-23)21(28-32)18-12-31(29-27-18)16-8-6-15(7-9-16)14(2)33/h6-9,12-13,17H,3-5,10-11H2,1-2H3,(H2,24,25,26)/t17-/m1/s1 | | Definition date: | 2018-11-28 | | Last modified: | 2024-09-27 | | Release date: | 2019-02-27 | | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one |
|
 | | 323 | | Name: | 2-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate | | Formula: | C25 H22 N2 O4 | | SMILES: | [O-]C(=O)c4cc(C=O)ccc4C=1c3c(OC=2C=1C=C/C(=[N+](/C)C)C=2)cc(cc3)N(C)C | | InChi: | InChI=1S/C25H22N2O4/c1-26(2)16-6-9-19-22(12-16)31-23-13-17(27(3)4)7-10-20(23)24(19)18-8-5-15(14-28)11-21(18)25(29)30/h5-14H,1-4H3 | | Synonyms: | 5-Carboxy-N,N'-tetramethyl rhodamine | | Definition date: | 2008-06-30 | | Last modified: | 2024-09-27 | | Identifier: | 2-[6-(dimethylamino)-3-(dimethyliminio)-3H-xanthen-9-yl]-5-formylbenzoate |
|
 | | 9EF | | Name: | N-[2-(acetylamino)ethyl]-N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide | | Formula: | C13 H26 N3 O8 P | | SMILES: | O=P(O)(O)OCC(C)(C(C(NCCC(=O)NCCNC(=O)C)=O)O)C | | InChi: | InChI=1S/C13H26N3O8P/c1-9(17)14-6-7-15-10(18)4-5-16-12(20)11(19)13(2,3)8-24-25(21,22)23/h11,19H,4-8H2,1-3H3,(H,14,17)(H,15,18)(H,16,20)(H2,21,22,23)/t11-/m0/s1 | | Definition date: | 2018-03-27 | | Last modified: | 2024-09-27 | | Release date: | 2018-06-13 | | Identifier: | N-[2-(acetylamino)ethyl]-N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide |
|
 | | 9EP | | Name: | (2R)-5-[(acetyloxy)methyl]-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic
acid | | Formula: | C16 H18 N2 O6 S2 | | SMILES: | O=CC(NC(=O)Cc1sccc1)C2SCC(=C(N2)C(=O)O)COC(=O)C | | InChi: | InChI=1S/C16H18N2O6S2/c1-9(20)24-7-10-8-26-15(18-14(10)16(22)23)12(6-19)17-13(21)5-11-3-2-4-25-11/h2-4,6,12,15,18H,5,7-8H2,1H3,(H,17,21)(H,22,23)/t12-,15-/m1/s1 | | Synonyms: | Cephalotin, bound form | | Definition date: | 2010-06-28 | | Last modified: | 2024-09-27 | | Identifier: | (2R)-5-[(acetyloxy)methyl]-2-{(1R)-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|